These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 1286168

  • 1. The bcl-2 oncogene and apoptosis.
    Hockenbery DM.
    Semin Immunol; 1992 Dec; 4(6):413-20. PubMed ID: 1286168
    [Abstract] [Full Text] [Related]

  • 2. Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death.
    Korsmeyer SJ, Shutter JR, Veis DJ, Merry DE, Oltvai ZN.
    Semin Cancer Biol; 1993 Dec; 4(6):327-32. PubMed ID: 8142617
    [Abstract] [Full Text] [Related]

  • 3. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.
    Strasser A, Harris AW, Bath ML, Cory S.
    Nature; 1990 Nov 22; 348(6299):331-3. PubMed ID: 2250704
    [Abstract] [Full Text] [Related]

  • 4. BCL-2 gene family and the regulation of programmed cell death.
    Korsmeyer SJ.
    Cancer Res; 1999 Apr 01; 59(7 Suppl):1693s-1700s. PubMed ID: 10197582
    [Abstract] [Full Text] [Related]

  • 5. Bcl-2: an antidote to programmed cell death.
    Korsmeyer SJ.
    Cancer Surv; 1992 Apr 01; 15():105-18. PubMed ID: 1451107
    [Abstract] [Full Text] [Related]

  • 6. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
    Capaccioli S, Quattrone A, Schiavone N, Calastretti A, Copreni E, Bevilacqua A, Canti G, Gong L, Morelli S, Nicolin A.
    Oncogene; 1996 Jul 04; 13(1):105-15. PubMed ID: 8700536
    [Abstract] [Full Text] [Related]

  • 7. Insights from transgenic mice regarding the role of bcl-2 in normal and neoplastic lymphoid cells.
    Cory S, Harris AW, Strasser A.
    Philos Trans R Soc Lond B Biol Sci; 1994 Aug 30; 345(1313):289-95. PubMed ID: 7846127
    [Abstract] [Full Text] [Related]

  • 8. Bcl-6 p53 mutations in lymphomas carrying the bcl-2/Jh rearrangement.
    Bellido M, Capello D, Altés A, Estivill C, Gaidano G, Pujol R, Bordes R, Baiget M, Saglio G, Sierra J, Nomdedéu JF.
    Haematologica; 2002 Sep 30; 87(9):908-17. PubMed ID: 12217802
    [Abstract] [Full Text] [Related]

  • 9. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia.
    Limpens J, de Jong D, van Krieken JH, Price CG, Young BD, van Ommen GJ, Kluin PM.
    Oncogene; 1991 Dec 30; 6(12):2271-6. PubMed ID: 1766674
    [Abstract] [Full Text] [Related]

  • 10. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
    Shinto Y, Morimoto M, Katsumata M, Uchida A, Aozasa K, Okamoto M, Kurosawa T, Ochi T, Greene MI, Tsujimoto Y.
    Oncogene; 1995 Nov 02; 11(9):1729-36. PubMed ID: 7478600
    [Abstract] [Full Text] [Related]

  • 11. Oligonucleotides induce apoptosis restricted to the t(14;18) DHL-4 cell line.
    Morelli S, Alama A, Quattrone A, Gong L, Copreni E, Canti G, Nicolin A.
    Anticancer Drug Des; 1996 Jan 02; 11(1):1-14. PubMed ID: 8639245
    [Abstract] [Full Text] [Related]

  • 12. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.
    Hockenbery D, Nuñez G, Milliman C, Schreiber RD, Korsmeyer SJ.
    Nature; 1990 Nov 22; 348(6299):334-6. PubMed ID: 2250705
    [Abstract] [Full Text] [Related]

  • 13. Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis.
    Marin MC, Hsu B, Meyn RE, Donehower LA, el-Naggar AK, McDonnell TJ.
    Oncogene; 1994 Nov 22; 9(11):3107-12. PubMed ID: 7936633
    [Abstract] [Full Text] [Related]

  • 14. Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.
    Zörnig M, Busch G, Beneke R, Gulbins E, Lang F, Ma A, Korsmeyer S, Möröy T.
    Oncogene; 1995 Nov 16; 11(10):2165-74. PubMed ID: 7478538
    [Abstract] [Full Text] [Related]

  • 15. The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo.
    Marin MC, Hsu B, Stephens LC, Brisbay S, McDonnell TJ.
    Exp Cell Res; 1995 Apr 16; 217(2):240-7. PubMed ID: 7698223
    [Abstract] [Full Text] [Related]

  • 16. The bcl-2 gene and 14;18 translocation in lymphoproliferative disorders.
    Pezzella F, Mason DY.
    Nouv Rev Fr Hematol (1978); 1990 Apr 16; 32(6):397-9. PubMed ID: 2101872
    [Abstract] [Full Text] [Related]

  • 17. Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in severe combined immunodeficient mice bearing human t(14;18) follicular lymphoma.
    Mohammad R, Abubakr Y, Dan M, Aboukameel A, Chow C, Mohamed A, Hamdy N, Al-Katib A.
    Clin Cancer Res; 2002 Apr 16; 8(4):1277-83. PubMed ID: 11948143
    [Abstract] [Full Text] [Related]

  • 18. Bax accelerates tumorigenesis in p53-deficient mice.
    Knudson CM, Johnson GM, Lin Y, Korsmeyer SJ.
    Cancer Res; 2001 Jan 15; 61(2):659-65. PubMed ID: 11212265
    [Abstract] [Full Text] [Related]

  • 19. Regulation of B cell survival in xid mice by the proto-oncogene bcl-2.
    Woodland RT, Schmidt MR, Korsmeyer SJ, Gravel KA.
    J Immunol; 1996 Mar 15; 156(6):2143-54. PubMed ID: 8690903
    [Abstract] [Full Text] [Related]

  • 20. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation.
    Ngan BY, Chen-Levy Z, Weiss LM, Warnke RA, Cleary ML.
    N Engl J Med; 1988 Jun 23; 318(25):1638-44. PubMed ID: 3287162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.